Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
US Department of Justice

Generated: March 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020925

« Back to Dashboard

NDA 020925 describes TAVIST-1, which is a drug marketed by Glaxosmithkline Cons and Novartis and is included in two NDAs. It is available from one supplier. Additional details are available on the TAVIST-1 profile page.

The generic ingredient in TAVIST-1 is clemastine fumarate. There are two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the clemastine fumarate profile page.
Summary for 020925
Applicant:Glaxosmithkline Cons
Ingredient:clemastine fumarate
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020925
Suppliers and Packaging for NDA: 020925
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TAVIST-1 clemastine fumarate TABLET;ORAL 020925 NDA Novartis Consumer Health, Inc. 0067-1190 N 0067-1190-08
TAVIST-1 clemastine fumarate TABLET;ORAL 020925 NDA Novartis Consumer Health, Inc. 0067-1190 N 0067-1190-16

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength1.34MG
Approval Date:Aug 21, 1992TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Argus Health
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.